Project outline
Outcome
Role
Scope
Methods
iCount needed a new name to enter the US market. I led a 5-phase, research-driven renaming process
Board-approved name, launch messaging concept initiated
Design lead (reporting directly to the CEO), led a UX writer (Ido)
Brand positioning, research design, naming strategy, validation
Market analysis, linguistic & cultural analysis, quantitative user research (n=300)

iCount, an Israeli accounting platform, needed a new name to enter the US market - one that was legally clear, culturally credible, and built to last. I led a five-phase, research-driven renaming process that ended with a board-approved name and the start of a new launch messaging system. Along the way, the validation data challenged my own hypothesis - and the most interesting result wasn't which name won, but what it revealed about how US users decide to trust financial software.
This was not simply a renaming exercise; it was a market-entry decision that would shape positioning, messaging, and product perception.
A US expansion attempt one and a half years prior had already resulted in a selected domain and name.
The contracted team's chosen name - Klyme - misrepresented the product and carried an obvious risk: Lyme disease. This was later validated in our audience survey, where over 40% of first-impression responses referenced disease or illness.
Reopening the decision meant challenging a sunk investment and prior executive approval. I demonstrated that long-term positioning risk outweighed the sunk cost, and I was given ownership to lead a structured, research-led renaming process.
I aligned with the UX copywriter (Ido), CEO, and PM on what the name needed to do.
It was decided that the new name must:
These constraints were treated as design inputs, not blockers:
Ido and I added constraints aimed at longevity:

Our process spanned the following phases:
Phase 1: strategic framing
Purpose: establish what the name must do in the US market.
Phase 2: concept generation
Purpose: explore naming directions aligned to positioning, not individual words.
Phase 3: internal filtering and constraints check
Purpose: narrow down while respecting real-world limits.
Phase 4: stakeholder realignment
Purpose: ****address leadership concerns while maintaining a structured, evidence-based approach.
Phase 5: market validation and risk mitigation
Purpose: reduce risk before board commitment.